Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs)

CompletedOBSERVATIONAL
Enrollment

94

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
HIV Infection
Trial Locations (19)

30029

Site Reference ID/Investigator# 27792, Nîmes

31000

Site Reference ID/Investigator# 27794, Toulouse

33075

Site Reference ID/Investigator# 27799, Bordeaux

34295

Site Reference ID/Investigator# 27786, Montpellier

35700

Site Reference ID/Investigator# 27791, Rennes

38043

Site Reference ID/Investigator# 27790, Grenoble

44093

Site Reference ID/Investigator# 27800, Nantes

49100

Site Reference ID/Investigator# 27801, Angers

59037

Site Reference ID/Investigator# 27796, Lille

75013

Site Reference ID/Investigator# 5595, Paris

75475

Site Reference ID/Investigator# 27787, Paris

75571

Site Reference ID/Investigator# 27797, Paris

75877

Site Reference ID/Investigator# 27783, Paris

75908

Site Reference ID/Investigator# 27802, Paris

75970

Site Reference ID/Investigator# 27785, Paris

76000

Site Reference ID/Investigator# 27788, Rouen

83056

Site Reference ID/Investigator# 27789, Toulon

94804

Site Reference ID/Investigator# 27784, Villejuif

06202

Site Reference ID/Investigator# 27798, Nice

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Readitwell

UNKNOWN

collaborator

Lincoln Medical and Mental Health Center

OTHER

lead

Abbott

INDUSTRY

NCT01103596 - Evaluation of the Public Health Interest of Kaletra: Impact on Resistance to Antiretrovirals (ARVs) | Biotech Hunter | Biotech Hunter